Sanofi Takes a $120M Hit as Potential Dengue Vaccine Blockbuster Dealt Safety Blow Post author:Sam Post published:November 29, 2017 Post category:BioPharma Sanofi’s setback could open the door for rival drugmaker Takeda. Source: BioSpace You Might Also Like Shocker: Life-Saving Portable Defibrillator Movement Plagued By Malfunctions March 30, 2017 Exelixis Announces Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update February 27, 2017 Voyager Founder and CEO to Step Down, Hunt for New Leader Begins January 31, 2018
Exelixis Announces Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update February 27, 2017
